CGTX Cognition Therapeutics, Inc. - Common Stock
CGTX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
CGTX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
CGTX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 2 22,2%
- Compra 6 66,7%
- Mantener 1 11,1%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
3 analistas · 2026-08-15Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.04 | $-0.06 | 0.02% |
| 31 de marzo de 2026 | $-0.05 | $-0.07 | 0.02% |
| 31 de diciembre de 2025 | $-0.05 | $-0.09 | 0.04% |
| 30 de septiembre de 2025 | $-0.06 | $-0.10 | 0.04% |
| 30 de junio de 2025 | $-0.11 | $-0.11 | -0.00% |
| 31 de marzo de 2025 | $-0.14 | $-0.11 | -0.03% |
| 31 de diciembre de 2024 | $-0.17 | $-0.14 | -0.03% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CGTX | $120M | -4.2 | — | — | -113.7% | — |
| PLYX | — | — | — | — | -193.7% | — |
| RANI | — | -3.0 | 58.9% | -1817.1% | -169.6% | — |
| RFL | — | -1.6 | 44.0% | -3328.2% | -34.6% | — |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | — |
| LONA | $71M | -0.3 | — | — | -353.4% | — |
| CING | — | — | — | — | — | — |
| ELOX | — | — | — | — | 30.1% | — |
| TELO | $46M | -4.0 | — | — | -325.7% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 12
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $37M | $42M | $37M | $30M | $19M | $13M | |
| SG&A Expense | $11M | $12M | $14M | $13M | $10M | $5M | |
| Operating Expenses | $48M | $54M | $51M | $44M | $29M | $17M | |
| Operating Income | $-48M | $-54M | $-51M | $-44M | $-29M | $-17M | |
| Other Non-op | $24M | $20M | $25M | $22M | $17M | $10M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-23M | $-34M | $-26M | $-21M | $-12M | $-8M | |
| EPS (Basic) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | $-23.76 | |
| EPS (Diluted) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | $-23.76 | |
| Shares (Basic) | 72,766,983 | 39,730,148 | 30,029,087 | 23,640,199 | 5,190,883 | 508,112 | |
| Shares (Diluted) | 72,766,983 | 39,730,148 | 30,029,087 | 23,640,199 | 5,190,883 | 508,112 | |
| EBITDA | $-48M | $-54M | $-51M | $-43M | $-29M | · |
Balance general 22
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $25M | $30M | $42M | $55M | $5M | |
| Prepaid Expense | $1M | $2M | $3M | $2M | $2M | $544.0K | |
| Other Current Assets | · | · | · | · | $11.0K | $23.0K | |
| Current Assets | $48M | $30M | $34M | $48M | $59M | $7M | |
| PP&E (Net) | $93.0K | $181.0K | $284.0K | $233.0K | $145.0K | $211.0K | |
| PP&E (Gross) | $280.0K | $1M | $1M | $1M | $1M | $988.0K | |
| Accum. Depreciation | $187.0K | $1M | $1M | $953.0K | $870.0K | $777.0K | |
| Total Assets | $48M | $30M | $35M | $50M | $59M | $7M | |
| Accounts Payable | $1M | $2M | $4M | $3M | $4M | $2M | |
| Accrued Liabilities | $12M | $8M | $4M | $2M | $2M | $994.0K | |
| Current Liabilities | $14M | $11M | $10M | $8M | $8M | $3M | |
| Capital Leases | $195.0K | $342.0K | $520.0K | $695.0K | · | · | |
| Deferred Tax | $67.0K | $110.0K | $147.0K | $178.0K | $13.0K | $22.0K | |
| Other Non-current Liabilities | · | · | $0 | $2M | $0 | · | |
| Total Liabilities | $14M | $11M | $11M | $10M | $8M | $20M | |
| Common Stock | $90.0K | $60.0K | $32.0K | $29.0K | $22.0K | $1.0K | |
| Paid-in Capital | $233M | $194M | $166M | $156M | $145M | $222.0K | |
| Retained Earnings | $-199M | $-175M | $-141M | $-115M | $-94M | $-68M | |
| AOCI | · | · | $-195.0K | $-199.0K | $-198.0K | $-187.0K | |
| Stockholders' Equity | $34M | $19M | $24M | $40M | $51M | $-68M | |
| Liabilities + Equity | $48M | $30M | $35M | $50M | $59M | $7M | |
| Shares Outstanding | 88,904,161 | 59,854,877 | 32,165,478 | 28,991,548 | 22,230,032 | 538,793 |
Flujo de Efectivo 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $36.0K | $107.0K | $96.0K | $83.0K | $93.0K | $98.0K | |
| Stock-based Comp | $2M | $4M | $4M | $4M | $5M | $475.0K | |
| Deferred Tax | · | $0 | $0 | $0 | · | · | |
| Other Non-cash | $-3M | $2M | $5M | $-791.0K | $3M | · | |
| Operating Cash Flow | $-25M | $-28M | $-16M | $-19M | $-4M | $-3M | |
| CapEx | · | $4.0K | $147.0K | $171.0K | $27.0K | $10.0K | |
| Investing Cash Flow | $9.0K | $-4.0K | $-147.0K | $-171.0K | $-27.0K | $-10.0K | |
| Financing Cash Flow | $37M | $24M | $5M | $6M | $53M | $6M | |
| Net Change in Cash | $12M | $-5M | $-12M | $-13M | $50M | $2M | |
| Free Cash Flow | · | $-28M | $-16M | $-19M | $-4M | · |
Rentabilidad 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | 187866.7% | 155539.3% | 3202.5% | · | |
| Net Margin | · | · | 95511.1% | 76417.9% | 1312.0% | · | |
| EBITDA Margin | · | · | 187511.1% | 155242.9% | 3192.1% | · | |
| ROA | -59.8% | -103.9% | -60.3% | -39.1% | -35.4% | · | |
| ROE | -113.7% | -204.5% | -96.6% | -53.8% | 66.1% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 2.7 | 3.4 | 6.1 | 7.5 | · | |
| Quick Ratio | 2.6 | 2.2 | 2.9 | 5.3 | 7.0 | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | -0.0 | -0.0 | -0.0 | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $-28.0K | $-28.0K | $-27.0K | $-28.0K | $-893.0K | · | |
| Net Income TTM | $-23M | $-34M | $-26M | $-21M | $-12M | · | |
| Market Cap | $120M | $42M | $60M | $61M | $140M | · | |
| P/E | -4.2 | -0.8 | -2.2 | -2.3 | -2.0 | · | |
| P/S | -4286.5 | -1498.5 | -2203.9 | -2174.4 | -157.3 | · | |
| P/B | 3.5 | 2.2 | 2.4 | 1.5 | 2.7 | · | |
| P / Tangible Book | 3.5 | 2.2 | 2.4 | 1.5 | 2.7 | · | |
| P / Cash Flow | -4.9 | -1.5 | -3.7 | -3.3 | -38.7 | · | |
| P / FCF | · | -1.5 | -3.7 | -3.3 | -38.4 | · | |
| Earnings Yield | -23.7% | -122.7% | -46.5% | -43.3% | -49.5% | · |
Estado de resultados 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $5M | $6M | $11M | $4M | $11M | $11M | $8M | $11M | $12M | $11M | $12M | $12M | $8M | $5M | $6M | $8M | |
| SG&A Expense | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $3M | $4M | |
| Operating Expenses | $8M | $9M | $14M | $6M | $14M | $14M | $11M | $14M | $15M | $14M | $15M | $15M | $12M | $9M | $9M | $13M | |
| Operating Income | $-8M | $-9M | $-14M | $-6M | $-14M | $-14M | $-11M | $-14M | $-15M | $-14M | $-15M | $-15M | $-12M | $-9M | $-9M | $-13M | |
| Other Non-op | $4M | $4M | $10M | $1M | $7M | $5M | $3M | $5M | $8M | $5M | $7M | $8M | $7M | $3M | $4M | $6M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | $-6M | · | · | |
| Net Income | $-4M | $-5M | $-3M | $-5M | $-7M | $-8M | $-8M | $-10M | $-7M | $-9M | $-8M | $-7M | $-5M | $-6M | $-5M | $-7M | |
| EPS (Basic) | $-0.04 | $-0.05 | $-0.01 | $-0.06 | $-0.11 | $-0.14 | $-0.16 | $-0.25 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.16 | $-0.21 | $-0.20 | $-0.29 | |
| EPS (Diluted) | $-0.04 | $-0.05 | $-0.01 | $-0.06 | $-0.11 | $-0.14 | $-0.16 | $-0.25 | $-0.18 | $-0.27 | $-0.27 | $-0.22 | $-0.16 | $-0.21 | $-0.20 | $-0.29 | |
| Shares (Basic) | 90,624,381 | 89,191,313 | -130,703,624 | 77,951,513 | 63,690,945 | 61,828,149 | -74,486,140 | 40,418,065 | 40,062,954 | 33,735,269 | -59,045,833 | 30,365,506 | 29,614,822 | 29,094,592 | -44,406,168 | 23,024,026 | |
| Shares (Diluted) | 90,624,381 | 89,191,313 | -130,703,624 | 77,951,513 | 63,690,945 | 61,828,149 | -74,486,140 | 40,418,065 | 40,062,954 | 33,735,269 | -59,045,833 | 30,365,506 | 29,614,822 | 29,094,592 | -44,406,168 | 23,024,026 | |
| EBITDA | $-8M | $-9M | · | $-6M | $-14M | $-14M | · | $-14M | $-15M | $-14M | · | $-15M | $-12M | $-9M | · | $-13M |
Balance general 21
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $31M | $37M | $39M | $11M | $16M | $25M | $22M | $29M | $35M | $30M | $33M | $37M | $39M | $42M | $47M | |
| Prepaid Expense | $586.0K | $932.0K | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $1M | $2M | $2M | $2M | $2M | |
| Current Assets | $38M | $36M | $48M | $43M | $19M | $23M | $30M | $27M | $34M | $38M | $34M | $36M | $42M | $43M | $48M | $51M | |
| PP&E (Net) | $87.0K | $77.0K | $93.0K | $159.0K | $174.0K | $190.0K | $181.0K | $207.0K | $234.0K | $257.0K | $284.0K | $281.0K | $248.0K | $253.0K | $233.0K | $246.0K | |
| PP&E (Gross) | · | · | $280.0K | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $187.0K | · | · | · | $1M | · | · | · | $1M | · | · | · | $953.0K | · | |
| Total Assets | $39M | $36M | $48M | $43M | $20M | $24M | $30M | $28M | $34M | $39M | $35M | $39M | $44M | $46M | $50M | $54M | |
| Accounts Payable | $673.0K | $4M | $1M | $827.0K | $771.0K | $2M | $2M | $2M | $3M | $3M | $4M | $3M | $4M | $3M | $3M | $8M | |
| Accrued Liabilities | $4M | $2M | $12M | $4M | $9M | $8M | $8M | $10M | $6M | $5M | $4M | $4M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $5M | $6M | $14M | $7M | $12M | $11M | $11M | $13M | $11M | $10M | $10M | $8M | $8M | $7M | $8M | $12M | |
| Capital Leases | $422.0K | $176.0K | $195.0K | $212.0K | $229.0K | $280.0K | $342.0K | $392.0K | $440.0K | $488.0K | $520.0K | $565.0K | $608.0K | $651.0K | $695.0K | $603.0K | |
| Deferred Tax | · | · | $67.0K | · | · | · | $110.0K | · | · | · | $147.0K | · | · | · | $178.0K | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $1M | $1M | $2M | $2M | $2M | |
| Total Liabilities | $6M | $6M | $14M | $7M | $13M | $11M | $11M | $13M | $11M | $10M | $11M | $10M | $10M | $10M | $10M | $14M | |
| Common Stock | $95.0K | $90.0K | $90.0K | $88.0K | $65.0K | $62.0K | $60.0K | $41.0K | $40.0K | $40.0K | $32.0K | $30.0K | $30.0K | $29.0K | $29.0K | $24.0K | |
| Paid-in Capital | $240M | $233M | $233M | $232M | $197M | $196M | $194M | $182M | $180M | $179M | $166M | $162M | $161M | $158M | $156M | $150M | |
| Retained Earnings | $-207M | $-203M | $-199M | $-195M | $-190M | $-184M | $-175M | $-167M | $-157M | $-150M | $-141M | $-133M | $-126M | $-122M | $-115M | $-110M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $-195.0K | $-196.0K | $-196.0K | $-195.0K | $-199.0K | $-201.0K | |
| Stockholders' Equity | $33M | $30M | $34M | $37M | $7M | $12M | $19M | $14M | $23M | $29M | $24M | $29M | $34M | $36M | $40M | $39M | |
| Liabilities + Equity | $39M | $36M | $48M | $43M | $20M | $24M | $30M | $28M | $34M | $39M | $35M | $39M | $44M | $46M | $50M | $54M | |
| Shares Outstanding | 95,055,773 | 89,353,773 | 88,904,161 | 88,268,078 | 64,962,957 | 61,974,755 | 59,854,877 | 40,806,092 | 40,112,268 | 39,985,866 | 32,165,478 | 30,417,082 | 30,286,582 | 29,277,227 | 28,991,548 | 23,969,497 |
Flujo de Efectivo 11
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $14.0K | $15.0K | · | · | $27.0K | $27.0K | $26.0K | $27.0K | $27.0K | $25.0K | $23.0K | $21.0K | $23.0K | $22.0K | |
| Stock-based Comp | $319.0K | $330.0K | $358.0K | $522.0K | $621.0K | $586.0K | $534.0K | $896.0K | $1M | $1M | $1M | $1M | $1M | $1M | $902.0K | $777.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $709.0K | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-3M | $-6M | $-3M | $-6M | $-6M | $-10M | $-8M | $-7M | $-6M | $-7M | $-5M | $-4M | $-4M | $-3M | $-10M | $-4.0K | |
| CapEx | · | · | · | · | · | · | $1.0K | $0 | · | · | $30.0K | $58.0K | $18.0K | $41.0K | $10.0K | $23.0K | |
| Investing Cash Flow | · | · | · | · | · | · | $-1.0K | $0 | · | · | $-30.0K | $-58.0K | $-18.0K | $-41.0K | $-10.0K | $-23.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $197.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $197.0K | · | · | |
| Financing Cash Flow | $7M | $-233.0K | $605.0K | $34M | $752.0K | $1M | $11M | $329.0K | $-138.0K | $12M | $2M | $-3.0K | $2M | $-10.0K | $5M | $869.0K | |
| Net Change in Cash | $4M | $-6M | $-3M | $28M | $-5M | $-9M | $3M | $-7M | $-6M | $5M | $-3M | $-4M | $-2M | $-3M | $-5M | $839.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | · |
Rentabilidad 6
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | 141020.0% | · | 737250.0% | 196950.0% | 89730.0% | · | 631250.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | 91510.0% | · | 337450.0% | 78766.7% | 61720.0% | · | 331250.0% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | 78766.7% | 61720.0% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | 140750.0% | · | 737250.0% | 196950.0% | 89520.0% | · | 631250.0% | |
| ROA | -13.4% | -15.3% | · | -13.9% | -24.9% | -27.2% | · | -29.9% | -18.0% | -21.7% | · | -14.6% | -9.8% | -11.8% | · | -19.8% | |
| ROE | -19.6% | -21.7% | · | -19.3% | -44.8% | -41.2% | · | -45.8% | -24.5% | -28.3% | · | -19.8% | -12.1% | -14.6% | · | 28.0% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 5.9 | · | 6.4 | 1.5 | 2.1 | · | 2.1 | 3.1 | 4.0 | · | 4.4 | 5.3 | 5.7 | · | 4.2 | |
| Quick Ratio | 6.2 | 5.1 | · | 5.9 | 0.9 | 1.5 | · | 1.7 | 2.6 | 3.6 | · | 4.0 | 4.7 | 5.2 | · | 3.8 |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | -0.0 | · | 0.0 | -0.0 | -0.0 | · | -0.0 |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $-28.0K | $-28.0K | · | $-28.0K | $-28.0K | $-28.0K | · | $-28.0K | $-28.0K | $-28.0K | · | $-20.0K | $-25.0K | $-28.0K | · | · | |
| Net Income TTM | $-20M | $-25M | · | $-30M | $-32M | $-35M | · | $-33M | $-28M | $-27M | · | $-24M | $-23M | $-22M | · | $-19M | |
| Market Cap | $109M | $68M | · | $119M | $20M | $26M | · | $19M | $67M | $73M | · | $44M | $55M | $58M | · | $46M | |
| P/E | -4.4 | -2.1 | · | -2.4 | -0.5 | -0.5 | · | -0.5 | -2.0 | -2.1 | · | -1.6 | -2.0 | -2.2 | · | -0.2 | |
| P/S | -3904.1 | -2425.3 | · | -4255.8 | -719.2 | -931.8 | · | -683.5 | -2378.1 | -2599.1 | · | -2190.0 | -2217.0 | -2070.3 | · | · | |
| P/B | 3.3 | 2.3 | · | 3.3 | 2.9 | 2.1 | · | 1.3 | 2.9 | 2.5 | · | 1.5 | 1.6 | 1.6 | · | 1.2 | |
| P / Tangible Book | 3.3 | 2.3 | · | 3.3 | 2.9 | 2.1 | · | 1.3 | 2.9 | 2.5 | · | 1.5 | 1.6 | 1.6 | · | 1.2 | |
| P / Cash Flow | · | -12.3 | · | · | · | -2.6 | · | · | · | -10.0 | · | · | · | -21.4 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -21.1 | · | · | |
| Earnings Yield | -22.6% | -47.4% | · | -41.5% | -219.3% | -199.5% | · | -196.2% | -50.0% | -47.2% | · | -61.1% | -49.7% | -46.5% | · | -464.7% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Margen Operativo % | — | — | 187866.7% | 155539.3% | 3202.5% |
| Beneficio neto | $-23M | $-34M | $-26M | $-21M | $-12M |
| EPS Diluido | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 3.4 | 2.7 | 3.4 | 6.1 | 7.5 |
| Ratio Rápido | 2.6 | 2.2 | 2.9 | 5.3 | 7.0 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | — | $-28M | $-16M | $-19M | $-4M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 70 declarantes · $24.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 6 (-5 vs trimestre anterior) | 13 (+1 vs trimestre anterior) | 20 (+3 vs trimestre anterior) | 10 (-2 vs trimestre anterior) | +4.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BIOS Capital Management, LP | $6 324 891 | 5 499 905 | 26,03% | Acciones |
| DAVENPORT & Co LLC | $4 898 438 | 4 259 511 | 20,16% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 954 591 | 3 438 775 | 16,27% | Acciones |
| Chescapmanager LLC | $1 146 583 | 997 029 | 4,72% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $845 023 | 734 329 | 3,48% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $797 281 | 693 288 | 3,28% | Acciones |
| Hilton Capital Management, LLC | $631 293 | 548 950 | 2,60% | Acciones |
| VANGUARD GROUP INC | $625 973 | 463 684 | 2,58% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $584 453 | 508 220 | 2,41% | Acciones |
| CM Management, LLC | $517 500 | 450 000 | 2,13% | Acciones |
| Dauntless Investment Group, LLC | $427 456 | 371 701 | 1,76% | Acciones |
| Sigma Planning Corp | $416 605 | 362 265 | 1,71% | Acciones |
| STATE STREET CORP | $401 330 | 348 983 | 1,65% | Acciones |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $368 575 | 320 500 | 1,52% | Acciones |
| UBS Group AG | $251 316 | 218 536 | 1,03% | Acciones |
| AMERICAN FINANCIAL GROUP INC | $235 750 | 205 000 | 0,97% | Acciones |
| NORTHERN TRUST CORP | $204 932 | 178 202 | 0,84% | Acciones |
| Voss Capital, LP | $201 250 | 175 000 | 0,83% | Acciones |
| Texas Capital Bank Wealth Management Services Inc | $164 790 | 143 296 | 0,68% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $97 681 | 84 940 | 0,40% | Acciones |
| Corient Private Wealth LP | $93 480 | 81 287 | 0,38% | Acciones |
| XTX Topco Ltd | $90 242 | 78 471 | 0,37% | Acciones |
| McAdam, LLC | $74 236 | 64 553 | 0,31% | Acciones |
| FCA CORP /TX | $60 416 | 52 536 | 0,25% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $57 328 | 49 850 | 0,24% | Acciones |
| Circle Wealth Management, LLC | $56 168 | 48 842 | 0,23% | Acciones |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | $55 200 | 48 000 | 0,23% | Acciones |
| Bangor Savings Bank | $46 597 | 40 519 | 0,19% | Acciones |
| Essex Financial Services, Inc. | $46 000 | 40 000 | 0,19% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $45 521 | 40 644 | 0,19% | Acciones |
| GABELLI FUNDS LLC | $34 500 | 30 000 | 0,14% | Acciones |
| Bryn Mawr Trust Advisors, LLC | $33 408 | 29 050 | 0,14% | Acciones |
| MORGAN STANLEY | $32 054 | 27 873 | 0,13% | Acciones |
| HighTower Advisors, LLC | $30 475 | 26 500 | 0,13% | Acciones |
| PRIVATE MANAGEMENT GROUP INC | $27 600 | 24 000 | 0,11% | Acciones |
| Vanguard Global Advisers, LLC | $27 187 | 23 641 | 0,11% | Acciones |
| CWA Asset Management Group, LLC | $26 450 | 23 000 | 0,11% | Acciones |
| Creative Planning | $25 530 | 22 200 | 0,11% | Acciones |
| Qube Research & Technologies Ltd | $25 070 | 21 800 | 0,10% | Acciones |
| GAMCO INVESTORS, INC. ET AL | $23 000 | 20 000 | 0,09% | Acciones |
| Cetera Investment Advisers | $22 828 | 19 850 | 0,09% | Acciones |
| Rockefeller Capital Management L.P. | $22 116 | 19 231 | 0,09% | Acciones |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $20 087 | 17 467 | 0,08% | Acciones |
| Focus Partners Wealth | $19 838 | 17 250 | 0,08% | Acciones |
| Northeast Financial Consultants Inc | $19 627 | 63 351 | 0,08% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $18 344 | 15 951 | 0,08% | Acciones |
| CITIZENS FINANCIAL GROUP INC/RI | $15 731 | 13 679 | 0,06% | Acciones |
| Bank of New York Mellon Corp | $15 479 | 13 460 | 0,06% | Acciones |
| BRADLEY FOSTER & SARGENT INC/CT | $13 480 | 11 722 | 0,06% | Acciones |
| Vanguard Personalized Indexing Management, LLC | $13 334 | 11 595 | 0,05% | Acciones |
| ELEVATION POINT WEALTH PARTNERS, LLC | $11 546 | 10 040 | 0,05% | Acciones |
| Vestmark Advisory Solutions, Inc. | $11 546 | 10 040 | 0,05% | Acciones |
| MML INVESTORS SERVICES, LLC | $11 521 | 10 018 | 0,05% | Acciones |
| Robertson Stephens Wealth Management, LLC | $11 500 | 10 000 | 0,05% | Acciones |
| Retirement Planning Group, LLC | $11 500 | 10 000 | 0,05% | Acciones |
| Barry Investment Advisors, LLC | $11 500 | 10 000 | 0,05% | Acciones |
| Chicago Partners Investment Group LLC | $10 475 | 10 909 | 0,04% | Acciones |
| CITIGROUP INC | $8 763 | 7 620 | 0,04% | Acciones |
| FIFTH THIRD BANCORP | $5 750 | 5 000 | 0,02% | Acciones |
| OSAIC HOLDINGS, INC. | $4 830 | 4 200 | 0,02% | Acciones |
| Versant Capital Management, Inc | $3 746 | 3 257 | 0,02% | Acciones |
| Smith Anglin Financial, LLC | $3 718 | 12 000 | 0,02% | Acciones |
| WELLS FARGO & COMPANY/MN | $3 450 | 3 000 | 0,01% | Acciones |
| Global Retirement Partners, LLC | $2 300 | 2 000 | 0,01% | Acciones |
| Ariel Capital Advisors, LLC | $1 578 | 2 250 | 0,01% | Acciones |
| Rialto Wealth Management, LLC | $528 | 459 | 0,00% | Acciones |
| Virtu Financial LLC | $96 | 83 434 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $58 | 50 | 0,00% | Acciones |
| BlackRock, Inc. | $54 | 47 | 0,00% | Acciones |
| FMR LLC | $1 | 1 | 0,00% | Acciones |
Informantes de la empresa 13 insiders · 4 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Lisa Ricciardi | CEO & President | 16 de abril de 2026 P | 1 715 851 | 1 | 0 | $10 092 |
| John Brendan Doyle | Chief Financial Officer | 1 de mayo de 2026 F | 618 942 | 1 | 0 | $11 300 |
| James Michael O'Brien | Chief Financial Officer | 23 de marzo de 2022 A | 5 000 | 0 | 0 | $0 |
| Anthony Caggiano | Chief Medical Officer | 16 de abril de 2026 P | 874 906 | 1 | 0 | $11 100 |
| Peggy Wallace | Consejero | 17 de junio de 2026 A | 111 461 | 0 | 0 | $0 |
| Jack A. Khattar | Consejero | 17 de junio de 2026 A | 73 500 | 0 | 0 | $0 |
| Brett P Monia | Consejero | 17 de junio de 2026 A | 73 500 | 0 | 0 | $0 |
| Ellen B Richstone | Consejero | 17 de junio de 2026 A | 83 500 | 0 | 0 | $0 |
| Fletcher Aaron G.L. | Consejero | 19 de septiembre de 2025 M | 56 229 | 0 | 0 | $0 |
| Mark H. Breedlove | Consejero | 13 de octubre de 2021 X | 404 439 | 0 | 0 | $0 |
| Golden Seeds Cognition Therapeutics LLC | Propietario del 10% | 27 de septiembre de 2022 J | 0 | 0 | 0 | $0 |
| Ogden CAP Associates, LLC | Propietario del 10% | 13 de octubre de 2021 X | 2 210 377 | 0 | 0 | $0 |
| BIOS MEMORY SPV I, LP | Propietario del 10% | 13 de octubre de 2021 C | 60 065 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| BIOS MEMORY SPV I, LP, BIOS MEMORY SPV II, LP, BIOS FUND I, LP, BIOS FUND I QP, LP, BP DIRECTORS, LP, BIOS FUND II, LP, BIOS FUND II QP, LP, BIOS FUND II NT, LP, BIOS FUND III, LP, BIOS FUND III QP, LP, BIOS FUND III NT, LP, BIOS CLINICAL OPPORTUNITY FUND, LP, BIOS EQUITY PARTNERS, LP, BIOS EQUITY PARTNERS II, LP, BIOS EQUITY PARTNERS III, LP, BIOS EQUITY COF, LP, CAVU MANAGEMENT, LP, BIOS CAPITAL MANAGEMENT, LP, CAVU ADVISORS, LLC, BIOS ADVISORS GP, LLC, LESLIE W. KREIS, AARON G.L. FLETCHER ×5 presentaciones | 23 de septiembre de 2025 | 6,80% | Enmienda | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 4 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,09% | 6 057 SH | 8 de agosto de 2026 | Diario |
| IWC · iShares Trust | 0,02% | 275 235 SH | 8 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 923 898 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 444 295 SH | 8 de agosto de 2026 | Diario |